[Sample Collection] Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients (MTG-022)

Condition: Various Indications

Sponsor: MT Group

Protocol MTG-022: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients - Blood sample collection study with constantly changing set of available cohorts.

For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.